VNDA 最新季度財報
公佈日期10/28/2026
實際每股收益(美元)-0.37
實際營收(美元)69.81M
本頁面提供詳細的 Vanda Pharmaceuticals Inc 財報數據,包括最新財報、下一次財報發佈日期、歷史數據,以及 Vanda Pharmaceuticals Inc 財報法說會相關新聞。
| 發布日期 | 報告期末 | 每股收益/預測值 | 營收/預測值 | 每股收益超出預期幅度% | 營收超出預期幅度% |
|---|---|---|---|---|---|
| 10/28/2026 | 09/2026 | -0.37/-0.68 | 69.81M/69.20M | 45.29% | 0.89% |
| 8/6/2026 | 06/2026 | -1.04/-0.59 | 50.53M/61.92M | -76.67% | -18.40% |
| 5/6/2026 | 03/2026 | -0.82/-0.69 | 51.72M/54.98M | -18.72% | -5.93% |
| 2/11/2026 | 12/2025 | -2.39/-1.32 | 57.22M/59.27M | -80.30% | -3.47% |
| 10/29/2025 | 09/2025 | -0.38/-0.45 | 56.26M/58.73M | 15.69% | -4.21% |
| 7/31/2025 | 06/2025 | -0.46/-0.36 | 52.59M/54.60M | -29.30% | -3.68% |
| 5/7/2025 | 03/2025 | -0.50/-0.60 | 50.04M/45.13M | 15.54% | 10.87% |
| 2/13/2025 | 12/2024 | -0.08/-0.11 | 53.19M/52.25M | 21.03% | 1.79% |
萬達製藥 (VNDA) 2026 年第三季財報電話會議:營收成長 24%,費用下降